Aplnature Co. – Trademark Portfolio
Entity Type: 03
Aplnature Co. has 5 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 are successfully registered — a 60% registration rate. The portfolio includes marks such as [DA ; MEAL]. Filings span 4 Nice Classification classes, with the highest activity in Class 5 (Pharmaceuticals) and Class 35 (Advertising & Business). This trademark owner is based in Seoul.
401, 620, Samseong-ro
Gangnam-gu
Seoul 06085 , KR
Showing of trademarks Trademarks
Trademark Classifications
Aplnature Co.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Aplnature Co. have?
Aplnature Co. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 1 cancelled.
What trademark classes does Aplnature Co. file in?
Aplnature Co. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Aplnature Co.'s most well-known trademarks?
Aplnature Co.'s registered trademark portfolio includes well-known marks such as [DA ; MEAL]. These are among 3 currently registered trademarks in the portfolio.
What is Aplnature Co.'s trademark registration success rate?
Aplnature Co. has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.